Literature DB >> 22050735

Comparison of the pig and feline models for full thickness corneal transplantation.

Isabelle Brunette1, Serge G Rosolen, Michel Carrier, Mona Abderrahman, Ossama Nada, Lucie Germain, Stéphanie Proulx.   

Abstract

PURPOSE: The goal of this study was to report on the advantages and limitations of the pig and feline models for experimental in vivo corneal transplantation.
METHODS: Ten healthy domestic pigs and ten healthy cats were used. Full thickness penetrating keratoplasty was performed using autologous (eight cases), allogeneic (seven cases) or human xenogeneic (three cases) tissue. In two other cases, the inflammatory response to partial thickness trephination (without transplantation) was evaluated. Eyes were assessed daily before and after surgery by slit-lamp, pachymetry, and tonometry. A transparency score ranging from 0 (opaque graft) to 4 (clear graft) was used, based on the slit-lamp examination. Optical coherence tomography, histology, and electron microscopy were performed postmortem.
RESULTS: In the pig, the mean (±SD) transparency score for the eight full thickness grafts was 0.88 ± 0.99, ranging from 0 to 3. In the feline model, the mean transparency score for the seven uncomplicated grafts was 3.93 ± 0.19, ranging from 3.5 to 4. Both negative controls without endothelium remained opaque at all time. Intraoperative tendency for iris incarceration into the wound, rapid corneal swelling, suture cheese wiring, and postoperative intraocular inflammation were the main factors jeopardizing the functional success of the corneal transplant in the pig model.
CONCLUSION: Suboptimal functional results were obtained after full thickness corneal transplantation in the pig model, while in the feline model, the same protocol yielded uneventful surgeries and clear transplants, with functional results similar to those achieved in human subjects.
© 2011 American College of Veterinary Ophthalmologists.

Entities:  

Mesh:

Year:  2011        PMID: 22050735     DOI: 10.1111/j.1463-5224.2011.00886.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  6 in total

1.  Animal model with structural similarity to human corneal collagen fibrillar arrangement.

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; Logan Mitchell; George J Dias
Journal:  Anat Sci Int       Date:  2021-01-03       Impact factor: 1.741

2.  A Liquid Hydrogel to Restore Long Term Corneal Integrity After Perforating and Non-Perforating Trauma in Feline Eyes.

Authors:  Alejandro Juarez; Mohamed Djallali; Marilyse Piché; Mathieu Thériault; Marc Groleau; Sharifa Beroual; Christopher D McTiernan; Grace Lin; Pierre Hélie; Michel Carrier; May Griffith; Isabelle Brunette
Journal:  Front Bioeng Biotechnol       Date:  2021-12-15

3.  Interspecies comparative morphological evaluation of the corneal epithelial stem cell niche: a pilot observational study.

Authors:  Petya Popova; Fernando Malalana; Simon Biddolph; Tiago Ramos; Mohit Parekh; Julian Chantrey; Sajjad Ahmad
Journal:  J Vet Sci       Date:  2022-07       Impact factor: 1.603

4.  Keratocyte apoptosis and not myofibroblast differentiation mark the graft/host interface at early time-points post-DSAEK in a cat model.

Authors:  Adam J Weis; Krystel R Huxlin; Christine L Callan; Margaret A DeMagistris; Holly B Hindman
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

5.  Contributions of ocular surface components to matrix-metalloproteinases (MMP)-2 and MMP-9 in feline tears following corneal epithelial wounding.

Authors:  Andrea Petznick; Michele C Madigan; Qian Garrett; Deborah F Sweeney; Margaret D M Evans
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

6.  In Vivo Functionality of a Corneal Endothelium Transplanted by Cell-Injection Therapy in a Feline Model.

Authors:  Cristina Bostan; Mathieu Thériault; Karolyn J Forget; Christelle Doyon; J Douglas Cameron; Stéphanie Proulx; Isabelle Brunette
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.